Yet, in contrast to clinically relevant targets like HER2 or MUC-1, uPAR is also abundant in various noncancerous cells present in the activated tumor-supporting stroma, including cancer-associated fibroblasts (CAFs), macrophages, neutrophils, and endothelial cells (11). The gene discussed is PLAUR; the disease is neoplasm.